Mesolimbic Nociceptin Signaling and Cocaine Reward Suppression
- Institution
- UNIV OF MASSACHUSETTS MED SCH WORCESTER, MA
- Principal investigator
- Haley E Melikian
- Funding
- $209K
- Duration
- 2024–2026
Moonbase score
Still being scored
Abstract
Addiction is a pressing public health concern that impacts millions of people in the U.S, causing a sizable burden on the health care system and thousands of unnecessary deaths, 1 in 5 of which are due to psychostimulant abuse, such as cocaine. However, the mechanisms that control response to cocaine are not clearly defined, and there is a pressing need to understand these mechanisms. The current study will explore the possibility that the neuropeptide, NOF/Q (aka: nociceptin), is a potent cocaine reward suppressor that acts in mesolimbic terminal regions of the nucleus accumbens (NAc). Preliminary data strongly support that NOF/Q signaling in NAc blocks cocaine reward, and that NOF/Q can act directly upon DAergic terminals within NAc. However, the mechanisms and circuitry that mediate NOF/Q reward suppression in NAc are completely undefined, nor is it known whether there is basal NOF/Q tone in NAc that constitutively sets sensitivity to rewarding substances. The proposed exploratory studies will leverage a variety of cutting-edge viral and genetic tools to fully characterize NOF/Q tone and effects on reward in NAc, as well as the NOF/Q circuitry innervating NAc and that likely serve as an endogenous reward suppression system. Studies in Aim 1 will provide an in-depth analysis of cocaine reward suppression by NOF/Q in male and female mice, and leverage optogenetics in PNOCCre mice to determine whether endogenous NOF/Q signaling is sufficient to suppress cocaine reward. Studies in Aim 2 will leverage NOPRfl/fl mice to test whether NOF/Q signaling on DAergic mesolimbic terminals is required for cocaine suppression by NOF/Q. In addition, Aim 2 studies will use PNOCCre mice to retrogradely trace NOF/Q afferents in NAc, to the likely source of endogenous NOF/Q. Taken together, these studies will provide a fundamental understanding of the potential for NOF/Q signaling as powerful suppressant of cocaine reward, and will shed light on an intrinsic mechanism that sets reward tone. Importantly, the findings will lay the necessary groundwork for future work aimed at understanding the mechanisms and specific circuits that mediate NOF/Q reward suppression.
LOADING MOONBASE SCORE
Questions for UNIV OF MASSACHUSETTS MED SCH WORCESTER
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · Univ of Massachusetts Med Sch Worcester68
Comprehensive Harmonization and Analysis of Case/Control Whole Genome Sequencing Data from the ALS/FTD Compute Project
John E Landers · $817K · 2023–2028
- NIH · Univ of Massachusetts Med Sch Worcester47
Understanding Frontotemporal Dementia Using Drosophila and iPSC Models
Fen-Biao Gao · $626K · 2017–2027
- NIH · Univ of Massachusetts Med Sch Worcester41
New Technologies for detecting extracellular fluxes
William R Kobertz · $364K · 2021–2026